Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Convalescent plasma associates with reduced mortality and improved clinical trajectory in patients hospitalized with COVID-19
Shanna A. Arnold Egloff, Angela G. Junglen, Joseph S.A. Restivo, et al.
Journal of Clinical Investigation (2021) Vol. 131, Iss. 20
Open Access | Times Cited: 46

Showing 1-25 of 46 citing articles:

A guide to immunotherapy for COVID-19
Frank L. van de Veerdonk, Evangelos J. Giamarellos‐Bourboulis, Peter Pickkers, et al.
Nature Medicine (2022) Vol. 28, Iss. 1, pp. 39-50
Open Access | Times Cited: 276
Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (September 2022)
Adarsh Bhimraj, Rebecca L. Morgan, Amy Hirsch Shumaker, et al.
Clinical Infectious Diseases (2022) Vol. 78, Iss. 7, pp. e250-e349
Open Access | Times Cited: 120
COVID-19 Convalescent Plasma and Clinical Trials: Understanding Conflicting Outcomes
Daniele Focosi, Massimo Franchini, Liise-anne Pirofski, et al.
Clinical Microbiology Reviews (2022) Vol. 35, Iss. 3
Open Access | Times Cited: 89
Clinical Practice Guidelines From the Association for the Advancement of Blood and Biotherapies (AABB): COVID-19 Convalescent Plasma
Lise J Estcourt, Claudia S. Cohn, Monica B. Pagano, et al.
Annals of Internal Medicine (2022) Vol. 175, Iss. 9, pp. 1310-1321
Open Access | Times Cited: 63
Mortality Rates Among Hospitalized Patients With COVID-19 Treated With Convalescent Plasma: A Systematic Review and Meta-Analysis
Jonathon W. Senefeld, Ellen K. Gorman, Patrick W. Johnson, et al.
Mayo Clinic Proceedings Innovations Quality & Outcomes (2023) Vol. 7, Iss. 5, pp. 499-513
Open Access | Times Cited: 28
Convalescent plasma therapy in COVID-19: Unravelling the data using the principles of antibody therapy
Arturo Casadevall, Michael J. Joyner, Liise-anne Pirofski, et al.
Expert Review of Respiratory Medicine (2023) Vol. 17, Iss. 5, pp. 381-395
Closed Access | Times Cited: 25
Antibodies from convalescent plasma promote SARS-CoV-2 clearance in individuals with and without endogenous antibody response
Maddalena Marconato, Irène A. Abela, Anthony Hauser, et al.
Journal of Clinical Investigation (2022) Vol. 132, Iss. 12
Open Access | Times Cited: 32
Use of covid-19 convalescent plasma to treat patients admitted to hospital for covid-19 with or without underlying immunodeficiency: open label, randomised clinical trial
Karine Lacombe, Thomas Hueso, Raphaël Porcher, et al.
BMJ Medicine (2023) Vol. 2, Iss. 1, pp. e000427-e000427
Open Access | Times Cited: 16
Estimates of actual and potential lives saved in the United States from the use of COVID-19 convalescent plasma
Quigly Dragotakes, Patrick W. Johnson, Matthew R. Buras, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 41
Open Access | Times Cited: 5
Efficacy of convalescent plasma therapy in the patient with COVID-19: a randomised control trial (COPLA-II trial)
Meenu Bajpai, Ashish Maheshwari, Vikas Dogra, et al.
BMJ Open (2022) Vol. 12, Iss. 4, pp. e055189-e055189
Open Access | Times Cited: 25
Mechanistic insight into the protective and pathogenic immune-responses against SARS-CoV-2
Prabhat Kumar Purbey, Koushik Roy, Sandeep Gupta, et al.
Molecular Immunology (2023) Vol. 156, pp. 111-126
Open Access | Times Cited: 12
Estimates of Actual and Potential Lives Saved in the United States from the use of COVID-19 Convalescent Plasma
Quigly Dragotakes, Patrick W. Johnson, Matthew R. Buras, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 4
Prospective individual patient data meta-analysis of two randomized trials on convalescent plasma for COVID-19 outpatients
Pere Millat-Martínez, Arvind Gharbharan, Andrea Alemany, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 21
COVID‐19 and the impact on blood availability and transfusion practices in low‐ and middle‐income countries
Linda Barnes, Arwa Z. Al‐Riyami, Tina S. Ipe, et al.
Transfusion (2022) Vol. 62, Iss. 2, pp. 336-345
Open Access | Times Cited: 18
How do I implement an outpatient program for the administration of convalescent plasma for COVID‐19?
Evan M. Bloch, Aaron A.R. Tobian, Shmuel Shoham, et al.
Transfusion (2022) Vol. 62, Iss. 5, pp. 933-941
Open Access | Times Cited: 18
Timing of convalescent plasma administration and 28-day mortality in COVID-19 pneumonia
Soledad González, Lorena Regairaz, Martín R. Salazar, et al.
Journal of Investigative Medicine (2022) Vol. 70, Iss. 5, pp. 1258-1264
Open Access | Times Cited: 15
Avoided and avoidable deaths with the use of COVID-19 convalescent plasma in Italy during the first two years of pandemic
Massimo Franchini, Arturo Casadevall, Quigly Dragotakes, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Outcomes of Convalescent Plasma with Defined High versus Lower Neutralizing Antibody Titers against SARS-CoV-2 among Hospitalized Patients: CoronaVirus Inactivating Plasma (CoVIP) Study
Luther A. Bartelt, Alena J. Markmann, Bridget Nelson, et al.
mBio (2022) Vol. 13, Iss. 5
Open Access | Times Cited: 12
Mortality rates among hospitalized patients with COVID-19 treated with convalescent plasma A Systematic review and meta-analysis
Jonathon W. Senefeld, Ellen K. Gorman, Patrick W. Johnson, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 7
Effectiveness of COVID-19 Convalescent Plasma (CCP) During the Pandemic Era: A Literature Review
Usha Rani Kandula, Techane Sisay Tuji, Dinkinesh Begna Gudeta, et al.
Journal of Blood Medicine (2023) Vol. Volume 14, pp. 159-187
Open Access | Times Cited: 7
Inborn Errors of Immunity and Autoimmune Disease
Paul Gray, Clémentine David
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 11, Iss. 6, pp. 1602-1622
Closed Access | Times Cited: 7
Severe COVID‐19 represents an undiagnosed primary immunodeficiency in a high proportion of infected individuals
Paul Gray, Adam Bartlett, Stuart G. Tangye
Clinical & Translational Immunology (2022) Vol. 11, Iss. 4
Open Access | Times Cited: 10
Sensitivity of SARS-CoV-2 Variants to Neutralization by Convalescent Sera and a VH3-30 Monoclonal Antibody
Shuai Yue, Zhirong Li, Lin Yao, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 13
The Importance of Geographic Proximity of Convalescent Plasma Donors
Katie L. Kunze, Patrick W. Johnson
Current topics in microbiology and immunology (2024)
Closed Access | Times Cited: 1
Evidence for the Efficacy of COVID-19 Convalescent Plasma
Stephen A. Klassen, Jonathon W. Senefeld
Current topics in microbiology and immunology (2024)
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top